Therapeutic Applications of Pretargeting

Targeted therapies, such as radioimmunotherapy (RIT), present a promising treatment option for the eradication of tumor lesions. RIT has shown promising results especially for hematologic malignancies, but the therapeutic efficacy is limited by unfavorable tumor-to-background ratios resulting in hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Verhoeven, Marjolein, Seimbille, Yann, Dalm, Simone U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781323/
https://www.ncbi.nlm.nih.gov/pubmed/31480515
http://dx.doi.org/10.3390/pharmaceutics11090434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781323/
https://www.ncbi.nlm.nih.gov/pubmed/31480515
http://dx.doi.org/10.3390/pharmaceutics11090434

Ejemplares similares